Built on Purpose, Growing with Heart CINCINNATI, OH / ACCESS Newswire / June 3, 2025 / In just one year, AcutePet Urgent Care ...

Thermogenic Hydration Formula Backed by Cold-Induced Fat Burning Science Now Gaining Attention for Safe, Sustainable Weight ...

Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...

MUNICH, GERMANY AND LONDON, UK / ACCESS Newswire / June 3, 2025 / Infineon Technologies AG, a world leader in semiconductor solutions, today announced a strategic partnership with The Healthcare ...

Longevity Method, a leader in advanced health and wellness solutions, announces the launch of Live Longer - NMN+, a revolutionary NMN supplement designed to enhance cellular health and combat ...

One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes This data supports a strong safety profile for the VCFix® Spinal System for the ...

Simris Group AB (publ), through its wholly owned subsidiary Simris Biologics GmbH, has signed a non-binding concept sheet with a EU based biopharmaceutical company specializing in the development of ...

CenExel is pleased to announce the appointment of Samantha Stellenberg as the Interim Chief Operating Officer at CenExel Atlanta GA. With nearly two decades of experience in clinical research and an ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

Industry Leading RBQM Event Returns for 2025Expert Speaker Lineup announced for CluePoints Sponsored RBQMLive 2025King of Prussia, PA – June 3, 2025: CluePoints, the premier sponsor of RBQMLive and ...

Qlucore, a leading provider of powerful visualization-based bioinformatics data analysis tools, announces the launch of a new version of Qlucore Omics Explorer in the cloud. The new release includes ...

Notice to convene extraordinary GENERAL MEETING REGARDING EXTRAORDINARY DIVIDENDGUBRA A/SCVR NO. 30 51 40 41To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby given to convene an ...